BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/6/2026 6:30:43 AM | Browse: 0 | Download: 0
 |
Received |
|
2025-10-10 00:59 |
|
Peer-Review Started |
|
2025-10-10 00:59 |
|
First Decision by Editorial Office Director |
|
2025-11-18 09:55 |
|
Return for Revision |
|
2025-11-18 09:55 |
|
Revised |
|
2025-12-01 05:55 |
|
Publication Fee Transferred |
|
2025-12-03 10:22 |
|
Second Decision by Editor |
|
2026-01-13 02:36 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-01-13 07:03 |
|
Articles in Press |
|
2026-01-13 07:03 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-01-26 10:29 |
|
Publish the Manuscript Online |
|
2026-02-06 06:30 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Lipid metabolism in pancreatic cancer treatment
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Chi Zhang, Hao Wang and Yan-Hui Yang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Scientific and Technological Research (Key) Project of The First Affiliated Hospital of Henan University of Science and Technology |
No. ZLKFJJ20230408 |
|
| Corresponding Author |
Yan-Hui Yang, Associate Professor, Chief, MD, Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, No. 24 Jing-Hua Road, Luoyang 471003, Henan Province, China. yangyanhui63@163.com |
| Key Words |
Lipid metabolism; Pancreatic cancer; Cancer therapy; Immune suppression; Drug resistance |
| Core Tip |
This article highlights lipid metabolism reprogramming as a key driver of pancreatic cancer progression, inducing growth, metastasis, and immunosuppression. Targeting enzymes such as fatty acid synthase or cholesterol pathways shows promise in overcoming therapy resistance, offering innovative strategies to reshape treatment paradigms. |
| Publish Date |
2026-02-06 06:30 |
| Citation |
Zhang C, Wang H, Yang YH. Lipid metabolism in pancreatic cancer treatment. World J Clin Oncol 2026; 17(2): 114959 |
| URL |
https://www.wjgnet.com/2218-4333/full/v17/i2/114959.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v17.i2.114959 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
